Associated Papers
Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia.
Umeda M et al.
Blood, 2025
A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC.
Wang Z et al.
Cellular & Molecular Biology Letters, 2025
Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia.
Umeda M et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
Digital RNA sequencing using unique molecular identifiers enables ultrasensitive RNA mutation analysis.
Luna Santamaría M et al.
Communications Biology, 2024
Meta-Analysis of Keratoconus Transcriptomic Data Revealed Altered RNA Editing Levels Impacting Keratin Genomic Clusters.
Bortoletto E et al.
Investigative Ophthalmology & Visual Science, 2023
The Integrative Studies on the Functional A-to-I RNA Editing Events in Human Cancers.
Wu S et al.
Genomics, Proteomics & Bioinformatics, 2023
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
Chen KJ et al.
Molecular Carcinogenesis, 2023
Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity.
Gwak SH et al.
Oncology Research, 2023
The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50.
Gao C et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2022
AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer.
Ghalali A et al.
Experimental & Molecular Medicine, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development.
Williamson D et al.
Cell Reports, 2022
ADAR1 and its implications in cancer development and treatment.
Baker AR et al.
Trends in Genetics : Tig, 2022
Transcriptome Profiling of ADAR1 Targets in Triple-Negative Breast Cancer Cells Reveals Mechanisms for Regulating Growth and Invasion.
Baker AR et al.
Molecular Cancer Research : Mcr, 2022
A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.
Wei Y et al.
Cell Death & Disease, 2022
The role of RNA editing enzyme ADAR1 in human disease.
Song B et al.
Wiley Interdisciplinary Reviews. Rna, 2022
Germinal GLT8D1, GATAD2A and SLC25A39 mutations in a patient with a glomangiopericytal tumor and five different sarcomas over a 10-year period.
Beddok A et al.
Scientific Reports, 2021
Modeling molecular development of breast cancer in canine mammary tumors.
Graim K et al.
Genome Research, 2021
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
Kung CP et al.
Oncogene, 2021
Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama T et al.
Cellular and Molecular Life Sciences : Cmls, 2020
Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma.
Kong XY et al.
Nucleic Acids Research, 2020
The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Chalk AM et al.
Genome Biology, 2019
Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis.
Wang J et al.
Oncotarget, 2018
Characterization of RNA editome in primary and metastatic lung adenocarcinomas.
Peng L et al.
Oncotarget, 2017
Potential protein activity modifications of amino acid variants in the human transcriptome.
Zyla J et al.
Acta Biochimica Polonica, 2015
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014